Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Sackler

Purdue Pharma's $7B opioid settlement plan could get votes from victims and cities

A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

A judge is being asked to clear the way for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement

Besides the hefty financial reward, the settlement also ends the Sackler family’s ownership of Purdue Pharma and their ability to sell opioids in the U.S.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Purdue Pharma $7.4bn opioid settlement wins broad support from US states

The suit, brought by 55 attorneys general, will help compensate victims and fund addiction treatment programmes.

Al Jazeera

10 Times the Rich Used Charities to Hide Their Wealth

When you think about charitable giving, you probably picture genuine philanthropy and heartfelt generosity. However, the world of charitable tax avoidance reveals a darker side where some wealthy individuals have exploited the system for personal gain. These schemes don’t just bend the rules—they often break them entirely, costing taxpayers billions…

The Free Financial Advisor

Eat the rich films have run their course

The bland satire in "Death of a Unicorn" makes its message unappetizing; there are tastier options

Salon

Sackler family to pay $6.5 billion for their role in ‘fueling’ opioid epidemic which has killed hundreds of thousands

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

New York AG Blasts Sackler Family While Announcing $7.4 Billion Purdue Pharma Settlement: 'No Amount of Money Will Ever Fully Repair The Damage They Caused'

New York's AG shared news of The Sackler family and Purdue Pharma settlement, while stating "no amount of money" could reverse the destruction caused.

Latin Times

Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller

The Independent UK

Purdue Pharma Faces Challenges In Opioid Lawsuit Settlement

Purdue Pharma seeks new settlement after Supreme Court rejection in opioid crisis fallout.

Top News

The threat of litigation looms as Purdue Pharma returns to settlement talks

OxyContin maker Purdue Pharma, the family that owns it and lawyers for thousands of parties with claims against it are getting ready to work on a new settlement after the U.S. Supreme Court rejected the last one

The Independent UK

US supreme court decisions: the biggest cases this term and their outcomes

The court has wrapped up its term, issuing a string of blockbuster decisions with the conservative supermajority in the driver’s seat

The Guardian - US

Supreme Court rejects settlement with OxyContin maker Purdue Pharma over legal protections for the Sackler family that owned the company

The Supreme Court ruled 5-4 against an estimated US$6 billion Purdue Pharma bankruptcy plan on June 27, 2024, that would have shielded the Sackler family – which owned and controlled the company – from legal liability.

The Conversation

SCOTUS Reverses Purdue Pharma Opioid Settlement, Threatening Billions For Victims

The ruling dealt a blow to Purdue Pharma's bankruptcy reorganization plan, which aimed to allocate billions of dollars to victims of opioid addiction while shielding the Sackler family from future lawsuits.

International Business Times

Get all your
news in one place.

100’s of premium titles.
One news app.

France 24

US Supreme Court rejects $6 billion OxyContin settlement shielding Sackler family

The US Supreme Court on Thursday rejected OxyContin maker Purdue Pharma's $6 billion settlement that would have shielded the Sackler family, who owned the company and earned tens of billions as it flooded the country with the highly addictive drug, from future civil lawsuits over the role they played in…

Investors Business Daily

Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court

Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement.

Top News

Supreme Court Rejects Opioid Settlement Shielding Sackler Family

Supreme Court rejects opioid settlement involving Sackler family, citing bankruptcy law misalignment and potential unfairness to victims.

The Independent UK

Supreme Court shreds nationwide $6 billion opioid settlement plan in ruling against Sackler family

The Supreme Court said the Sackler family cannot use a Chapter 11 reorganization plan to protect themselves from civil liability

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - US

US supreme court blocks Purdue Pharma’s bankruptcy settlement that would shield Sacklers from lawsuits

Controversial deal would have protected billionaire family owners from further liability over US opioid epidemic

The Independent UK

The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma

The Supreme Court has rejected a nationwide settlement with OxyContin maker Purdue Pharma that would've shielded Sackler family members who own the company from civil lawsuits over the toll of opioids but also would've provided billions of dollars to combat the epidemic

Roll Call

Supreme Court blocks Purdue Pharma bankruptcy plan - Roll Call

The 5-4 opinion will send victims of the opioid crisis back to settlement negotiations with the company and the Sackler family.

Evening Standard

Battle for the museum review: Museums get a lot wrong, but then so does this book

In theory, I should like this book. It’s about the corruption of what Rachel Spence calls Planet Art, that, is museums and galleries, and there’s a lot of it about. It extends from the grossly inflated prices given to rubbish artefacts at auction, to the use of cultural philanthropy to…

The Guardian - UK

‘A crazy can-do mentality’: what made New York’s Met one of the world’s mega museums?

It has 1.5m artefacts, 6m visitors, 2,000 staff – and gets by on donations. Max Hollein, the Met’s Austrian-born boss, relives his first five years, when he faced accusations of hoarding, narco-philanthropy and male dominance

Evening Standard

American Mother by Diane Foley review: a searing story of Foley's search to find her son's IS killer

Any book seriously recommended by Patrick Radden Keefe needs to be investigated. The author of Say Nothing, his peerless study of the Troubles in Northern Ireland, and Empire of Pain, his never-less-than shocking investigation into the Sackler family, is one of the most formidable investigative journalists working today, so if…

WEKU

In 2023, opioid settlement funds flowed to states. Here's how it's going

Some $1.5 billion flowed to local government coffers this year, sparking debates about transparency and how to spend the money. Here are 5 takeaways from a year's worth of reporting on the issue.

1 2 3 4

People

[ Brett M. ] Kavanaugh

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Metropolitan Museum of Art

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.